第3章：综合老年评估（CGA）在医疗保健和护理环境中的应用：日本基于CGA的医疗保健指南2024的英文翻译

IF 2.4 4区医学 Q3 GERIATRICS & GERONTOLOGY

Geriatrics & Gerontology International Pub Date : 2025-03-16 DOI:10.1111/ggi.15088

Yuko Takeshita, Yasushi Takeya, Fumihiro Mizokami, Satoru Ebihara, Yukari Tsubata, Masahiro Akishita

{"title":"第3章：综合老年评估（CGA）在医疗保健和护理环境中的应用：日本基于CGA的医疗保健指南2024的英文翻译","authors":"Yuko Takeshita, Yasushi Takeya, Fumihiro Mizokami, Satoru Ebihara, Yukari Tsubata, Masahiro Akishita","doi":"10.1111/ggi.15088","DOIUrl":null,"url":null,"abstract":"Is comprehensive geriatric assessment (CGA) effective in nursing (nursing department) older adults?Is CGA effective for the provision of care for older adults by care workers (e.g., care managers and certified care workers)?Is the use of CGA effective for medication management in older adults?Is the use of CGA by pharmacists effective for performing medication reviews in older adults?Is CGA effective for the rehabilitation of older adults?Is CGA effective for ACP in older adults with comorbid malignancies or a history of malignancy?YT received lecture fees from Astellas Pharma, Daiichi Sankyo, and Merck & Co. YT received research funding from Ono Pharmaceutical and Pfizer Health Research Foundation, as well as lecture fees from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Kirin, Taiho Pharmaceutical, and Takeda. MA received research funding from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical Co., Daiichi Sankyo, Eisai, Merck & Co., Fukuda Lifetech, Mitsubishi-Tanabe Pharma, Ono Pharmaceutical, Takeda, and Tsumura as well as lecture fees from Daiichi Sankyo, Merck & Co., Toa Eiyo, and Towa Pharmaceutical. All other authors declare no conflict of interest.","PeriodicalId":12546,"journal":{"name":"Geriatrics & Gerontology International","volume":"25 S1","pages":"24-29"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ggi.15088","citationCount":"0","resultStr":"{\"title\":\"Chapter 3: Utilization of comprehensive geriatric assessment (CGA) in healthcare and caregiving settings by related professionals: English translation of the Japanese CGA-based healthcare guidelines 2024\",\"authors\":\"Yuko Takeshita, Yasushi Takeya, Fumihiro Mizokami, Satoru Ebihara, Yukari Tsubata, Masahiro Akishita\",\"doi\":\"10.1111/ggi.15088\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Is comprehensive geriatric assessment (CGA) effective in nursing (nursing department) older adults?Is CGA effective for the provision of care for older adults by care workers (e.g., care managers and certified care workers)?Is the use of CGA effective for medication management in older adults?Is the use of CGA by pharmacists effective for performing medication reviews in older adults?Is CGA effective for the rehabilitation of older adults?Is CGA effective for ACP in older adults with comorbid malignancies or a history of malignancy?YT received lecture fees from Astellas Pharma, Daiichi Sankyo, and Merck & Co. YT received research funding from Ono Pharmaceutical and Pfizer Health Research Foundation, as well as lecture fees from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Kirin, Taiho Pharmaceutical, and Takeda. MA received research funding from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical Co., Daiichi Sankyo, Eisai, Merck & Co., Fukuda Lifetech, Mitsubishi-Tanabe Pharma, Ono Pharmaceutical, Takeda, and Tsumura as well as lecture fees from Daiichi Sankyo, Merck & Co., Toa Eiyo, and Towa Pharmaceutical. All other authors declare no conflict of interest.\",\"PeriodicalId\":12546,\"journal\":{\"name\":\"Geriatrics & Gerontology International\",\"volume\":\"25 S1\",\"pages\":\"24-29\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-03-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ggi.15088\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Geriatrics & Gerontology International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ggi.15088\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatrics & Gerontology International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ggi.15088","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

综合老年评估（CGA）对护理（护理部门）老年人有效吗？CGA对于护理员（例如护理员和持证护理员）为老年人提供护理是否有效？使用CGA对老年人用药管理有效吗？药师使用CGA对老年人进行药物评价是否有效？CGA对老年人康复有效吗？CGA对合并恶性肿瘤或有恶性肿瘤史的老年人ACP有效吗？他从安斯泰来制药、第一三共制药和默克公司获得了演讲费。YT公司获得了小野制药和辉瑞健康研究基金会的研究经费，以及阿斯利康、百时美施贵宝、中盖制药、第一三共、协和麒麟、大ho制药和武田制药的演讲费用。MA获得了来自安斯泰来制药、拜耳雅库欣、中盖制药、第一三共、卫材、默克公司的研究经费；公司、福田生命科技、三菱田边制药、小野制药、武田和津村，以及第一三共、默克公司的演讲费；公司，Toa Eiyo和Toa Pharmaceutical。所有其他作者声明无利益冲突。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Chapter 3: Utilization of comprehensive geriatric assessment (CGA) in healthcare and caregiving settings by related professionals: English translation of the Japanese CGA-based healthcare guidelines 2024

查看原文本刊更多论文

Is comprehensive geriatric assessment (CGA) effective in nursing (nursing department) older adults?

Is CGA effective for the provision of care for older adults by care workers (e.g., care managers and certified care workers)?

Is the use of CGA effective for medication management in older adults?

Is the use of CGA by pharmacists effective for performing medication reviews in older adults?

Is CGA effective for the rehabilitation of older adults?

Is CGA effective for ACP in older adults with comorbid malignancies or a history of malignancy?

YT received lecture fees from Astellas Pharma, Daiichi Sankyo, and Merck & Co. YT received research funding from Ono Pharmaceutical and Pfizer Health Research Foundation, as well as lecture fees from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Kirin, Taiho Pharmaceutical, and Takeda. MA received research funding from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical Co., Daiichi Sankyo, Eisai, Merck & Co., Fukuda Lifetech, Mitsubishi-Tanabe Pharma, Ono Pharmaceutical, Takeda, and Tsumura as well as lecture fees from Daiichi Sankyo, Merck & Co., Toa Eiyo, and Towa Pharmaceutical. All other authors declare no conflict of interest.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Geriatrics & Gerontology International 医学-老年医学

CiteScore

5.50

自引率

6.10%

发文量

189

审稿时长

4-8 weeks

期刊介绍： Geriatrics & Gerontology International is the official Journal of the Japan Geriatrics Society, reflecting the growing importance of the subject area in developed economies and their particular significance to a country like Japan with a large aging population. Geriatrics & Gerontology International is now an international publication with contributions from around the world and published four times per year.